The most serious adverse events associated with GLP-1 agonists include acute pancreatitis, gallbladder disease (cholelithiasis and cholecystitis), and acute kidney injury secondary to dehydration from gastrointestinal side effects
Zepbound, which was first approved for weight management in November 2023, now offers new hope for those with obesity and obstructive sleep apnea, Eli Lilly reported
For instance, 50kg x 20mg = 1000mg
Thyroid Concerns In animal studies, semaglutide was linked to thyroid tumors, though this hasnt been confirmed in humans
PloS one 16 (5), e0250486
Inability to empty the bladder completely : Urinary retention or difficulty passing urine requires urgent assessment